Related Experiment Video

Updated: May 9, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Lipoprotein abnormalities in patients with type 2 diabetes and metabolic syndrome

Tania Dickson-Humphries1, B Bottenberg, Susan Kuntz

  • 1Carson Surgical Group, Carson City, Nevada, USA.

JAAPA : Official Journal of the American Academy of Physician Assistants
|August 8, 2013
PubMed

Insights

Aggressive treatment of insulin resistance and abnormal blood lipids is crucial for preventing cardiovascular disease, the leading cause of death. Addressing these metabolic issues is a priority for reducing heart disease morbidity and mortality.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Public Health

Background:

  • Cardiovascular disease (CVD) is the primary cause of mortality in the United States for both men and women.
  • Insulin resistance and dyslipidemia are significant risk factors contributing to CVD.
  • Effective management strategies for these metabolic abnormalities are essential for public health.

Purpose of the Study:

  • To emphasize the critical need for aggressive management of insulin resistance.
  • To highlight the importance of addressing associated lipid abnormalities in preventing CVD.
  • To underscore the priority of these interventions in reducing cardiovascular morbidity and mortality.

Main Methods:

  • This abstract does not detail specific methodologies.
  • The focus is on the clinical significance and public health implications of managing metabolic risk factors.
  • Literature review and clinical guidelines likely inform these recommendations.

Main Results:

  • The abstract does not present specific results from a particular study.
  • It highlights the established link between insulin resistance, lipid abnormalities, and cardiovascular outcomes.
  • Aggressive treatment is presented as a key strategy for risk reduction.

Conclusions:

  • Effective and aggressive treatment of insulin resistance and dyslipidemia is paramount.
  • These interventions are vital for mitigating cardiovascular morbidity and mortality.
  • Continued focus on metabolic health is essential for preventing premature death from heart disease.

More Related Videos

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...